Jeremy Skillington Chief Executive of Poolbeg Pharma

episode

Breakfast Business with Joe Lynam not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Breakfast Business with Joe Lynam

K-shaped economy 6 min · 23 Dec 2025

Medtech firm secures funding to support its push for US regulatory clearance 8 min · 23 Dec 2025

Tuesday's business headlines 3 min · 23 Dec 2025

Volatile Geopolitics the New Norm 7 min · 22 Dec 2025

Monday's business headlines 9 min · 22 Dec 2025

A positive picture for the domestic economy 7 min · 19 Dec 2025

All episodes from Breakfast Business with Joe Lynam →

Report any issue

Source

Recorded07 Aug 2026

Publisherrss.podplaystudio.com

Handlerec:19666292

Show notes

The Irish pharma company Poolbeg is working on one such cancer treatment to prevent distressing side effects. But Poolbeg is also looking at an oral GLP-1 or weight loss treatment as well. All of this research costs a lot of time and money and might not lead to anything. To discuss business of pharma was Jeremy Skillington the Chief Executive of Poolbeg Pharma.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in